SciSparc Ltd. SPRC
5.21
(0.18)
(3.34%)
as of 25 Sep
- Market cap
- $3.1M
- P/E
- 0.0×
Follow SPRC
Growth Flags
show if company had growth for consecutive years
| Jun '25 | Jun '24 | Jun '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | 0.00 | 0.00 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (236.32) | (164.86) | |
P/B ratio |
— | — | 112.72 | 146.45 | |
Price to Tangible BV |
— | — | 331.60 | 545.31 | |
EV/Sales |
— | — | 0.00 | 0.00 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (57.46) | (72.50) | |
EV/FCF |
— | — | (57.58) | (72.65) | |
Quick Ratio |
0.39 | 1.63 | 0.96 | 0.91 | |
Current Ratio |
0.55 | 1.86 | 1.17 | 1.09 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.79 | 1.09 | |
Debt/Assets |
47.23% | 0.00% | 0.00% | 0.25% | |
Debt/Equity |
(29.96) | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 1.12 | (1.81) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.27 | 0.29 | 0.45 | 0.44 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
— | — | 0.00 | 0.00 | |
Graham Number |
— | — | 0.00 | 0.00 | |
Earnings Yield |
— | — | (2.64%) | (1.70%) | |
Free Cash Flow Yield |
— | — | (1.73%) | (1.37%) | |
Revenue per Share |
— | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | (11.42) | (21.91) | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | (11.42) | (21.91) | |
Cash per Share |
0.00 | 0.00 | 7.50 | 13.90 | |
Shareholders Equity per Share |
0.00 | 0.00 | 23.93 | 24.66 | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 23.93 | 24.66 | |
Free Cash Flow |
(1.86) | (2.20) | (3.23) | (5.73) | |
Working Capital |
(2.29) | 1.56 | 0.53 | 0.35 | |
Capital Expenditures |
— | 0.00 | — | (4.87) | |
Net Current Asset Value |
(2.47) | 1.53 | 0.53 | 0.35 | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | 0.00% | 0.00% | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.54 | 1.44 | 0.79 | 0.23 | |
Average Payables |
0.84 | 1.18 | 0.80 | 0.88 | |
Average Assets |
9.78 | 10.20 | 9.12 | 6.58 | |
Average Common Equity |
1.48 | 8.40 | 7.18 | 3.94 |
Columns are period end dates